Ahn H J, Lim H K, Lee Y B, Hwang S M, Lee W S, Ahn S K, Choi E H
Department of Dermatology, Yonsei University Wonju College of Medicine, 162 Ilsan-Dong, Wonju, Kangwon-Do 220-701, Republic of Korea.
J Dermatol. 2001 Apr;28(4):208-16. doi: 10.1111/j.1346-8138.2001.tb00119.x.
In our previous study, we concluded that an epidural blockade combined with intravenous acyclovir is very effective in treating the acute pain in herpes zoster and postherpetic neuralgia. We evaluated the efficacy of oral famciclovir and epidural blockade on the pain of herpes zoster, compared to acyclovir administered intravenously and epidural blockade. For this purpose, we examined a new group treated with famciclovir and epidural blockade to compare with the group treated with acyclovir and epidural blockade in our previously study. The changes in the intensity of pain, the number of days required for relief of pain, and the total duration of pain were checked. We compared the days required for relief of pain (DRP) and the total duration of pain (TDP) of this group with those of the previous studied group treated with acyclovir and epidural blockade. DRP was significantly less, but TDP was similar. DRP and TDP were significantly lower, if the patients were treated within 7 days of symptom onset. The patients had a shorter DRP regardless of pain type than the previously studied group treated with acycolvir and epidural blockade. For the severe and moderate pain grades, there was a shorter DRP from 100 to 10. TDP was not significantly different for the groups regardless of pain type or grade. We believe that famciclovir and epidural blockade are very effective in treating the pain of herpes zoster, with a view to shortening the period of acute pain, providing similar effects on the prevention of postherpetic neuralgia, and being convenient to administer, compared to intravenous acyclovir and epidural blockade in our previous study.
在我们之前的研究中,我们得出结论:硬膜外阻滞联合静脉注射阿昔洛韦在治疗带状疱疹及带状疱疹后神经痛的急性疼痛方面非常有效。我们评估了口服泛昔洛韦和硬膜外阻滞对带状疱疹疼痛的疗效,并与静脉注射阿昔洛韦和硬膜外阻滞进行比较。为此,我们检查了一组接受泛昔洛韦和硬膜外阻滞治疗的新患者,以与我们之前研究中接受阿昔洛韦和硬膜外阻滞治疗的组进行比较。检查了疼痛强度的变化、疼痛缓解所需的天数以及疼痛的总持续时间。我们将该组的疼痛缓解天数(DRP)和疼痛总持续时间(TDP)与之前接受阿昔洛韦和硬膜外阻滞治疗的研究组进行了比较。DRP显著减少,但TDP相似。如果患者在症状出现后7天内接受治疗,DRP和TDP会显著降低。无论疼痛类型如何,患者的DRP均比之前接受阿昔洛韦和硬膜外阻滞治疗的研究组短。对于重度和中度疼痛等级,DRP从100降至10所需时间更短。无论疼痛类型或等级如何,各组的TDP均无显著差异。我们认为,与我们之前研究中的静脉注射阿昔洛韦和硬膜外阻滞相比,泛昔洛韦和硬膜外阻滞在治疗带状疱疹疼痛方面非常有效,有望缩短急性疼痛期,对预防带状疱疹后神经痛提供相似的效果,且给药方便。